TOPICS

Hokkaido University Participates in Inpart – Strengthening Academia–Industry Collaboration

2025.12.15

Hokkaido University Participates in Inpart – Strengthening Academia–Industry Collaboration

Hokkaido University is participating in Inpart, a global platform that connects academic research with industry partners. Through this engagement, the university aims to accelerate the social implementation of its research outcomes and promote collaborative innovation with companies both in Japan and abroad.

Stay Tuned for Upcoming Opportunities

Hokkaido University continues to share its cutting-edge research projects and collaboration opportunities on the Inpart platform. We invite companies, entrepreneurs, and research organizations to explore these listings and consider partnering with our distinguished researchers.
Please check back regularly for new opportunities. We encourage you to connect with us through Inpart or contact us directly to explore potential collaborations that can drive innovation and create societal impact.

Public Technologies

release date field title/link
2025.12.8 Life Science Development of Programmable Splice Regulatory RNA To Induce Skipping of Target Exons – Alternatives to Splicing Regulatory Antisense Oligonucleotides
2025.12.3 Life Science Novel Mammalian Cell Expression Vectors Capable of Producing High Levels of Exogenous Proteins
2025.11.14 Science Technology Rheology Platform for Real-Time Process Monitoring
2025.11.4 Science Technology Pressure Sensor Array Capable of Detecting Tactile Sensation
2025.10.16 Life Science STAP-1–Derived Peptide Inhibiting T Cell Activation for Treatment of Autoimmune and Allergic Diseases
2025.10.15 Life Science Stable RvE3 Derivatives for Type 2 Diabetes: A Novel Insulin-Sensitizing Therapeutic Approach
2025.10.1 Science Technology Cancellous Bone-Inspired Architectures for 3D-Printing
2025.9.16 Science Technology Plasma Measuring Device for EUV Light Source using Laser Thomson Scattering
2025.9.2 Science Technology High-performance solid-state electrochemical thermal switches with earth-abundant cerium oxide
2025.8.19 Life Science Meflin as an Innovative Biomarker and Therapeutic Target Development in Inflammatory Diseases
2025.8.19 Life Science Novel Lipidated cGAMP Derivatives with High Cell Membrane Permeability for STING-Dependent Cancer Immunotherapy
2025.8.8 Life Science Novel RNA Therapeutic Delivery to Hepatic Stellate Cells via PDGF-Mediated Uptake for Liver Fibrosis Therapy
2025.8.8 Life Science Unlocking Axonal Repair: Targeting Neutrophil NETs to Accelerate Peripheral Nerve Recovery
2025.8.8 Life Science A Novel Therapeutic Peptide Targeting Mitochondria Dysfunction and Neuroinflammation in Alzheimer’s Disease
2025.8.1 Life Science Novel Helper Lipids for Enhanced mRNA Delivery
2025.8.1 Life Science A Novel Antibody With Immunostimulatory Function, Selectively Binding to KIR2DS1

 What is Inpart?

Inpart is an international matchmaking platform that connects research institutions with over 6,000 companies worldwide. Through its unique combination of automated analysis and expert review, Inpart facilitates efficient, secure, and meaningful connections between researchers and industry stakeholders.

Universities and researchers can post summaries of their research, technologies, or collaboration proposals, while companies receive tailored alerts based on their interests and technology needs. All interactions are managed directly through the platform, ensuring confidentiality and ease of communication.

Learn more: https://app.in-part.com